Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 13 studies | 24% ± 9% | |
lung | 12 studies | 24% ± 7% | |
intestine | 7 studies | 25% ± 10% | |
kidney | 5 studies | 21% ± 6% | |
breast | 4 studies | 19% ± 4% | |
liver | 4 studies | 33% ± 18% | |
bone marrow | 3 studies | 28% ± 13% | |
brain | 3 studies | 26% ± 5% | |
lymph node | 3 studies | 22% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 11734.05 | 21 / 21 | 100% | 152.45 | 504 / 504 |
esophagus | 100% | 12171.34 | 1445 / 1445 | 100% | 194.71 | 183 / 183 |
pancreas | 100% | 7607.11 | 328 / 328 | 100% | 110.61 | 178 / 178 |
skin | 100% | 17680.94 | 1809 / 1809 | 100% | 147.66 | 472 / 472 |
stomach | 100% | 9296.46 | 359 / 359 | 100% | 173.54 | 286 / 286 |
thymus | 100% | 15890.78 | 653 / 653 | 100% | 121.39 | 605 / 605 |
uterus | 100% | 14653.26 | 170 / 170 | 100% | 158.91 | 459 / 459 |
lung | 100% | 15638.91 | 577 / 578 | 100% | 135.73 | 1155 / 1155 |
intestine | 100% | 11553.63 | 966 / 966 | 100% | 172.75 | 526 / 527 |
kidney | 100% | 12280.10 | 89 / 89 | 100% | 92.83 | 899 / 901 |
ovary | 100% | 13976.46 | 180 / 180 | 100% | 134.00 | 429 / 430 |
breast | 100% | 14710.35 | 459 / 459 | 100% | 139.22 | 1115 / 1118 |
prostate | 100% | 13086.97 | 245 / 245 | 100% | 112.91 | 500 / 502 |
liver | 100% | 8450.27 | 226 / 226 | 100% | 81.11 | 404 / 406 |
adrenal gland | 100% | 11155.08 | 258 / 258 | 99% | 92.13 | 228 / 230 |
brain | 80% | 2742.47 | 2124 / 2642 | 98% | 76.21 | 694 / 705 |
adipose | 100% | 14503.40 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 122.92 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 156.56 | 29 / 29 |
spleen | 100% | 16447.73 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 167.91 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 95.39 | 1 / 1 |
blood vessel | 100% | 11374.54 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 5474.32 | 850 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 9415.68 | 881 / 929 | 0% | 0 | 0 / 0 |
muscle | 81% | 2784.95 | 649 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0033119 | Biological process | negative regulation of RNA splicing |
GO_0006397 | Biological process | mRNA processing |
GO_0070886 | Biological process | positive regulation of calcineurin-NFAT signaling cascade |
GO_0051148 | Biological process | negative regulation of muscle cell differentiation |
GO_0000381 | Biological process | regulation of alternative mRNA splicing, via spliceosome |
GO_0008380 | Biological process | RNA splicing |
GO_0045595 | Biological process | regulation of cell differentiation |
GO_0043484 | Biological process | regulation of RNA splicing |
GO_0048025 | Biological process | negative regulation of mRNA splicing, via spliceosome |
GO_0075522 | Biological process | IRES-dependent viral translational initiation |
GO_0035307 | Biological process | positive regulation of protein dephosphorylation |
GO_0005730 | Cellular component | nucleolus |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003729 | Molecular function | mRNA binding |
GO_0003723 | Molecular function | RNA binding |
GO_0036002 | Molecular function | pre-mRNA binding |
GO_0008187 | Molecular function | poly-pyrimidine tract binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PTBP1 |
Protein name | Polypyrimidine tract-binding protein 1 Polypyrimidine tract-binding protein 1 (PTB) (57 kDa RNA-binding protein PPTB-1) (Heterogeneous nuclear ribonucleoprotein I) (hnRNP I) Polypyrimidine tract binding protein 1 |
Synonyms | hCG_20560 PTB |
Description | FUNCTION: Plays a role in pre-mRNA splicing and in the regulation of alternative splicing events. Activates exon skipping of its own pre-mRNA during muscle cell differentiation. Binds to the polypyrimidine tract of introns. May promote RNA looping when bound to two separate polypyrimidine tracts in the same pre-mRNA. May promote the binding of U2 snRNP to pre-mRNA. Cooperates with RAVER1 to modulate switching between mutually exclusive exons during maturation of the TPM1 pre-mRNA. Represses the splicing of MAPT/Tau exon 10 . Binds to polypyrimidine-rich controlling element (PCE) of CFTR and promotes exon skipping of CFTR exon 9, thereby antagonizing TIA1 and its role in exon inclusion of CFTR exon 9 . Plays a role in the splicing of pyruvate kinase PKM by binding repressively to a polypyrimidine tract flanking PKM exon 9, inhibiting exon 9 inclusion and resulting in exon 10 inclusion and production of the PKM M2 isoform . In case of infection by picornaviruses, binds to the viral internal ribosome entry site (IRES) and stimulates the IRES-mediated translation . . |
Accessions | ENST00000676227.1 A0A087WUW5 ENST00000589575.5 ENST00000394601.8 [P26599-2] ENST00000349038.8 [P26599-1] ENST00000635647.1 A0A6Q8PEX4 K7ELW5 A6NLN1 A0A087WTS6 ENST00000356948.11 [P26599-3] A0A0U1RRM4 ENST00000585956.5 ENST00000585932.5 K7EK45 ENST00000677277.1 ENST00000587191.3 A0A7I2V621 K7ES59 ENST00000621737.4 A0A7I2V4H6 ENST00000679114.1 ENST00000585535.2 A0A0D9SF20 ENST00000350092.8 A0A087WU68 ENST00000586481.5 P26599 ENST00000627714.2 K7EKJ7 |